Creation of a lipoprotein(a) model to forecast progression-free survival and severe adverse events in metastatic lung adenocarcinoma patients lacking driver genes and with PD-L1 TPS under 50% - Scorecard - MDSpire

Creation of a lipoprotein(a) model to forecast progression-free survival and severe adverse events in metastatic lung adenocarcinoma patients lacking driver genes and with PD-L1 TPS under 50%

  • By

  • Sicong Li

  • Yiyuan Cui

  • Yijing Yan

  • Hao Li

  • Yue Jin

  • Yufan Chen

  • Jingjie Yu

  • Li Feng

  • April 24, 2026

  • 0 min

Share

Clinical Scorecard: Creation of a lipoprotein(a) model to forecast progression-free survival and severe adverse events in metastatic lung adenocarcinoma patients lacking driver genes and with PD-L1 TPS under 50%

At a Glance

CategoryDetail
Condition
Key MechanismsRevise to ensure alignment with study results.
Target Population
Care Setting

Key Highlights

  • AUC

Guideline-Based Recommendations

Diagnosis

    Management

    • C
    • i
    • t
    • e
    • s
    • p
    • e
    • c
    • i
    • f
    • i
    • c
    • g
    • u
    • i
    • d
    • e
    • l
    • i
    • n
    • e
    • s
    • o
    • r
    • s
    • t
    • u
    • d
    • i
    • e
    • s
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Justify age and ECOG PS criteria.

        Clinical Best Practices

        • best_practices

        References

        Original Source(s)

        Related Content